Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen

AIDS. 2001 May 25;15(8):1071-3. doi: 10.1097/00002030-200105250-00022.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Microbial
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • Humans
  • Point Mutation*
  • RNA, Viral / analysis
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Stavudine / therapeutic use*
  • Viral Load
  • Zidovudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Zidovudine
  • Stavudine
  • HIV Reverse Transcriptase